Family Intervention for Black Teens With Type 1 Diabetes
(3Ms Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a program called The 3Ms 2.0, designed to assist Black teens with type 1 diabetes and their families. The goal is to determine if this program can improve diabetes management in teens and strengthen family relationships. Participants will either receive The 3Ms 2.0, which includes mobile phone resources for parents, or educational materials as part of standard care. Teens aged 10 to 14 who have had type 1 diabetes for at least six months and live within 30 miles of a study site are eligible, provided their primary caregiver is also willing to participate. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could enhance diabetes management and family support.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What prior data suggests that The 3Ms 2.0 intervention is safe for Black teens with type 1 diabetes?
Research has shown that the 3Ms 2.0 program, designed for Black teens with type 1 diabetes and their caregivers, is easy to use and safe. In similar studies, using the program on mobile devices resulted in no reports of serious side effects. Caregivers and healthcare providers found the digital format both user-friendly and helpful. This suggests the program is safe for families managing diabetes care.12345
Why are researchers excited about this trial?
Researchers are excited about The 3Ms 2.0 Intervention because it takes a family-centered approach to managing Type 1 Diabetes in Black teens, which is not typically emphasized in standard care options. Unlike conventional treatments that focus primarily on medical management through insulin therapy and glucose monitoring, this intervention aims to engage and educate the entire family to improve adherence and outcomes. By addressing cultural and familial dynamics, The 3Ms 2.0 Intervention has the potential to enhance support systems and improve long-term diabetes management for teens in a way that current treatments do not.
What evidence suggests that The 3Ms 2.0 Intervention is effective for improving glycemic control and family relationships in Black teens with type 1 diabetes?
Research shows that the 3Ms 2.0 program, which participants in this trial may receive, might help Black teens with Type 1 diabetes manage their condition better. An earlier study of the original 3Ms program found that teens managed their diabetes more effectively when their parents assisted with insulin doses and blood sugar checks. This new version of the program emphasizes building family support, which can reduce stress for both teens and their caregivers. By using mobile phones, 3Ms 2.0 facilitates family connection and involvement. Although more research is needed to confirm its effectiveness, early results suggest it could be a promising way to improve diabetes management.12356
Who Is on the Research Team?
Deborah A Ellis, Ph.D.
Principal Investigator
Wayne State University
Are You a Good Fit for This Trial?
This trial is for Black adolescents with type 1 diabetes and their primary caregivers. Participants should be interested in improving blood sugar control and family relationships related to diabetes management. The study seeks families willing to use mobile health tools like video clips and text messages.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive The 3Ms 2.0 intervention or Educational Attention Control over a six-month period
Data Collection
Data collected at baseline, 3 months, 6 months, and 12 months post-baseline, including questionnaires and blood samples for HbA1c
Follow-up
Participants are monitored for safety and effectiveness after the intervention
What Are the Treatments Tested in This Trial?
Interventions
- The 3Ms 2.0 Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Wayne State University
Lead Sponsor
National Institute on Minority Health and Health Disparities (NIMHD)
Collaborator